{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:41:29Z","timestamp":1790048489719,"version":"4.0.1"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A Western blot (immunoblot) assay (WBA) for the detection of immunoglobulin G antibodies to Shiga toxins Stx2 and Stx1 in sera from 110 patients with enteropathic hemolytic-uremic syndrome (53 culture confirmed to have Shiga toxin-producing\n            <jats:italic>Escherichia coli<\/jats:italic>\n            [STEC] infection) and 110 age-matched controls was established by using a chemiluminescence detection system. Thirty-nine (74%) of the 53 culture-confirmed cases were infections with STEC serotype O157, and 14 (26%) were associated with infection by other STEC serotypes. The frequency of an anti-Stx2 response following infection by a Stx2-producing strain (34 of 48 cases; 71%) was higher than that of an anti-Stx1 response following Stx1-producing STEC infection (4 of 10). Furthermore, the frequency of an anti-Stx2 response in 110 control sera (10%) was significantly higher than the frequency of an anti-Stx1 response (1.8%) (\n            <jats:italic>P<\/jats:italic>\n            = 0.0325). For STEC O157 culture-confirmed cases WBA for toxin detection had a diagnostic sensitivity of 71% and a specificity of 90%. Because of its high specificity the assay might be a helpful tool for diagnosing suspected STEC infection when tests of stool samples or serological tests against various lipopolysaccharide antigens are negative. Furthermore, the prevalence of anti-Stx antibodies in healthy controls probably reflects the population immunity to systemic Stx-associated disease. It can thus serve as a basis for comparing immunity levels in different populations and for considering future Stx toxoid immunization strategies.\n          <\/jats:p>","DOI":"10.1128\/jcm.39.6.2272-2279.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:40Z","timestamp":1027764220000},"page":"2272-2279","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":35,"title":["Antibody Response to Shiga Toxins Stx2 and Stx1 in Children with Enteropathic Hemolytic-Uremic Syndrome"],"prefix":"10.1128","volume":"39","author":[{"given":"Kerstin","family":"Ludwig","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Klinik und Poliklinik fu\u0308r Kinder-und Jugendmedizin1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Karmali","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Research Institute and Division of Microbiology, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, and Department of Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada M5G 1X82"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Sarkim","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Klinik und Poliklinik fu\u0308r Kinder-und Jugendmedizin1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bobrowski","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Medizinische Kernklinik und Poiklinik,3Universita\u0308ts-Krankenhaus Eppendorf, 20246 Hamburg, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Petric","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Research Institute and Division of Microbiology, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, and Department of Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada M5G 1X82"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Karch","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Institut fu\u0308r Hygiene und Mikrobiologie der Universita\u0308t Wu\u0308rzburg, 97080 Wu\u0308rzburg,4 Germany, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Mu\u0308ller-Wiefel","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Klinik und Poliklinik fu\u0308r Kinder-und Jugendmedizin1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Arbeitsgemeinschaft fu\u0308r Pa\u0308diatrische Nephrologie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"221","article-title":"A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria","volume":"276","author":"Aleksic S.","year":"1992","unstructured":"Aleksic S. Karch H. Bockem\u00fchl J. A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria.Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis.2761992221230","journal-title":"Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02092278"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.7.2509-2516.1997"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82049-9"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800068102"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(80)80918-5"},{"key":"e_1_3_2_8_2","unstructured":"Caprioli\nA.\nLuzzi\nI.\nSeganti\nL.\nMarchetti\nM.\nKarmali\nM. A.\nClarke\nI.\nBoyd\nB.\nFrequency and nature of verocytotoxin 2 (VT2) neutralizing activity in human and animal sera\nRecent advances in verocytotoxin-producing Escherichia coli infection.\nKarmali\nM. A.\nGoglio\nA. G.\n1994\n353\n356\nElsevier Sciences\nAmsterdam The Netherlands"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90801-U"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.11.1053"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/2.1.1"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.5.1172-1178.1994"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036079"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.7.1807-1810.1992"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.10.2604-2610.1993"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1988.tb02999.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.166.2.375-379.1986"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.8.3464-3467.1992"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.3.516-519.1996"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X-60.11.1454"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91795-6"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.5.775"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.1.15"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.6.1457-1463.1994"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.18.3.775-779.1977"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70217-8"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.1028"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709588"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.23.5.869-872.1986"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6162199"},{"key":"e_1_3_2_31_2","first-page":"65","article-title":"Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis","volume":"180","author":"O'Brien A. D.","year":"1992","unstructured":"O'Brien A. D. Tesh V. L. Donohue-Rolfe A. Jackson M. P. Olsnes S. Sandvig K. Lindberg A. A. Keusch G. T. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.Curr. Top. Microbiol. Immunol.18019926594","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2440287"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.9.2053-2057.1996"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.3.609-613.1997"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.4154-4167.1992"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303243081203"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199308000-00018"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80730-9"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-40-5-338"},{"key":"e_1_3_2_40_2","first-page":"201","article-title":"Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls","volume":"281","author":"Schmidt H.","year":"1994","unstructured":"Schmidt H. R\u00fcssmann H. Schwarzkopf A. Aleksic S. Heesemann J. Karch H. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls.Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis.2811994201213","journal-title":"Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.91.3.666"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.94.1.35"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.53.1.135-140.1986"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0890-8508(91)90007-7"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.6.2272-2279.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.6.2272-2279.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T01:15:55Z","timestamp":1646442955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.39.6.2272-2279.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1128\/JCM.39.6.2272-2279.2001"],"URL":"https:\/\/doi.org\/10.1128\/jcm.39.6.2272-2279.2001","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2000-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}